Showing results (1-10 of 19) with videos related to

Sort By:
Pageof 2
Pharmaceutical Development and Technology|June 5, 2019
Dextran-coated iron oxide nanoparticle for delivery of miR-29a to breast cancer cell lineSerap Yalcin
Cancer Biology & Medicine|September 9, 2017
BRAF mutation in colorectal carcinomas with signet ring cell componentSerap Yalcin, Onder Onguru
Anti-Cancer Agents in Medicinal Chemistry|July 28, 2021
The Cisplatin, 5-fluorouracil, Irinotecan, and Gemcitabine Treatment in Resistant 2D and 3D Model Triple Negative Breast Cancer Cell Line: ABCG2 Expression DataFatma Kubra Ata, Serap Yalcin
Cancer Chemotherapy and Pharmacology|November 2, 2019
The secondary metabolites produced by Lactobacillus plantarum downregulate BCL-2 and BUFFY genes on breast cancer cell line and model organism Drosophila melanogaster: molecular docking approachMelih Sentürk, Fahriye Ercan, Serap Yalcin
Current Computer-Aided Drug Design|May 11, 2022
<i>In vivo</i>, <i>in vitro</i> and Molecular Modelling Analysis of Isoquercetin, Roseoside, Coreximine, Anonaine, and Arianacin MoleculesFatma Kübra Ata, Fahriye Ercan, Serap Yalcin Azarkan
Drug and Chemical Toxicology|April 28, 2025
Computational investigation of m-acetamide and 3MPAEA: Characterization, toxicity, and molecular docking and dynamic analysesNevin Çankaya, Mehmet Hanifi Kebiroğlu, Serap Yalcin Azarkan
Anti-Cancer Agents in Medicinal Chemistry|March 12, 2020
Characterization of Gemcitabine Loaded Polyhydroxybutyrate Coated Magnetic Nanoparticles for Targeted Drug DeliveryMaryam Parsian, Pelin Mutlu, Serap Yalcin, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|September 8, 2014
Telomere 1 (POT1) gene expression and its association with telomerase activity in colorectal tumor samples with different pathological featuresAhu Izgi, Armagan Gunal, Serap Yalcin, et al.
Molecular Biology Reports|December 3, 2025
Investigation of cytotoxic, molecular and in silico effects of chlorambucil and tamoxifen on 2D/3D MDA-MB-231 and HeLa cancer cell modelsDurmuş Burak Demirkaya, Habibe Sema Arslan, Serap Yalcin Azarkan
American Journal of Therapeutics|August 20, 2014
Polyhydroxybutyrate-coated magnetic nanoparticles for doxorubicin delivery: cytotoxic effect against doxorubicin-resistant breast cancer cell lineSerap Yalcin, Gozde Unsoy, Pelin Mutlu, et al.
Pageof 2